INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against American Renal Associates Holdings, Inc. and Advises Investors with Losses to Contact the Firm

Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating American Renal Associates Holdings, Inc. (“American Renal” or the “Company”) (NYSE: ARA) concerning possible violations of federal securities laws.

If you purchased or otherwise acquired American Renal shares and would like more information regarding the investigation, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The investigation concerns whether the Company and certain of its officers and/or directors have engaged in Health Insurance Fraud and breached their fiduciary duties. According to some reports, American Renal has been luring patients away from affordable Medicare and Medicaid programs and convincing them to sign up with UnitedHealthcare of Florida, Inc., UnitedHealthcare of Ohio, Inc. and All Savers Insurance Company for dialysis services rendered to patients suffering from end-stage renal disease, in order to boost its own profits when billing.

If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160819005594/en/